According to reports from ET Now, the board of directors of Sanofi India, a constituent of BSE 1000, announced a final dividend of 480% for the financial year ended 31 December 2025. The company declared this dividend at its meeting held on 25 February 2026, translating to ₹48 per equity share of ₹10 each. As reported by ET Now, the company informed shareholders through an exchange filing stating they are pleased to announce this significant dividend recommendation.
As reported by ET Now, Sanofi India has fixed Wednesday, April 22, 2026 as the record date for payment of the final dividend to eligible members. The payment is subject to approval of members at the ensuing 70th Annual General Meeting and will be paid to those whose names appear in the Register of Members and Beneficial Owners as at the close of business hours on April 22, 2026. According to the company's exchange filing, this record date is based on details furnished by the Depositories NSDL and CDSL.
According to ET Now, Sanofi India is a prominent R&D-driven pharmaceutical company incorporated in 1956, specializing in diabetes, cardiology, thrombosis, central nervous system, and vaccines. As a subsidiary of France-based Sanofi, it maintains strong manufacturing presence in Goa and a diverse portfolio including Lantus, Combiflam, and Allegra. At the time of reporting, as per ET Now, Sanofi India shares were trading at ₹3,265.00, up by 0.07% from the previous closing price of ₹3,262.60.
As reported by ET Now, Sanofi India has maintained consistent dividend payments to shareholders. In 2025, the company distributed cash rewards twice - ₹75 in November and ₹117 in April. In 2024, the company provided dividends twice - ₹117 in May and ₹50 in March. This latest 480% dividend represents a significant increase from the company's previous dividend distributions, demonstrating strong financial performance and shareholder returns.
